The Kodak Case (2020): Options Accumulation on the Public Record

If the FUTU/TIGR case is the recent story still working its way through the courts, Eastman Kodak (KODK) is its fully-documented counterpart — an example of informed accumulation where the follow-through is on the public record.

The setup

In late July 2020, Kodak was in the middle of a spectacular spike. The catalyst was a $765 million US government loan to pivot the company into pharmaceutical ingredient manufacturing — an announcement that briefly turned a struggling film-era brand into a momentum stock.

Underneath the rally, the options tape was doing something notable.

The flow

Out-of-the-money put volume went from literally zero to nearly 203,000 contracts in two sessions — and our informed-accumulation reading climbed from a cold zero to a full alert in four days, driven entirely by that put surge:

2020-07-27   OTM put volume:        0     — quiet
2020-07-28   OTM put volume:   38,747     — building
2020-07-29   OTM put volume:  202,961     — surging
2020-07-30   OTM put volume:  167,158     ← ALERT fired
2020-08-04   OTM put volume:  107,415     ← accumulation peak

A build from a zero base to six figures of downside positioning — right at the top of a euphoric rally — is about as clean an accumulation signature as the tape produces. This is what the put/call ratio skew looks like when it goes one-directional in a hurry.

The documented outcome

Within days, the story turned. The SEC opened an insider-trading investigation into option grants timed around the loan, and the government froze the loan pending review. Kodak gave back nearly the entire spike — a −88% collapse from the highs.

Unlike most option-flow anecdotes, this one doesn't rest on inference: the investigation is a matter of public record. Someone was loading puts from a standing start days before the loan was pulled — and the aftermath was documented by regulators, not just charted after the fact.

What this case teaches

Two things:

1. Accumulation shows up against the crowd. The visible narrative was a moonshot; the options tape was quietly building for a fall. Informed accumulation is often contrarian to the headline — which is exactly why it's worth measuring separately from price momentum.
2. A clean signal is one you can also see fail. We pair documented winners like Kodak with the honest misses — names where the same signal fired but no real catalyst followed — because a track record you only see winning isn't a track record you can trust.

For the modern, sub-radar version of the same pattern — accumulation too small for any whale scanner to catch — see The FUTU/TIGR Case (2026).

The pattern beyond Kodak

Kodak isn't a lone anecdote — it sits in a small family of documented or plausibly information-driven builds the same detector surfaces. In 2012, Overseas Shipholding (OSG) saw episodic heavy put spikes days before it disclosed roughly half a billion dollars of previously-unreported tax liabilities, then filed for bankruptcy weeks later. In 2024, Cytokinetics (CYTK) accumulated steadily into an all-time high right before Novartis walked away from acquisition talks, collapsing the takeover premium. Different catalysts — a pulled loan, a hidden liability, a dead deal — same shape: quiet, one-sided, opening positioning ahead of an information-sensitive event.

The mechanic that ties them together is worth stating plainly. A build that starts from a near-zero base, persists across sessions, skews hard to one side, and opens fresh open interest rather than recycling old positions is the cleanest thing the tape produces — because it can't be waved off as routine hedging or a name simply catching a market-wide move.

Beyond these single-name situations, the largest cluster of documented cases isn't corporate at all — it's biotech. Trial and FDA readouts are binary events on known dates with unknown outcomes, the textbook venue for someone positioning ahead of a result, and the detector surfaces them repeatedly: heavy one-sided put accumulation into names that then failed a pivotal trial, from mid-cap biotechs to microcaps. Buying puts into a scheduled binary is, to be clear, perfectly legal event-driven trading — the tape can flag the accumulation but never the intent behind it. (Why that line matters so much: Does Unusual Options Flow Mean Insider Trading?) Kodak is the rare case where the intent question was answered on the public record instead of left to inference.

For holders, that carries a direct lesson: heavy put accumulation on a stock you own — even, especially, at the top of a euphoric rally — is a fragility warning, a reason to look at protection before the move rather than after.

See it live

Want to know if a name on your watchlist is building the same signature today? Create a free account — no credit card — and check your tickers against the live accumulation flags, graded by alert tier, on the Ideas board.

• Mapped to your investor style on the persona idea matrix.
• How we validate every signal on our methodology page.

Related reading

• Informed Accumulation Explained
• The FUTU/TIGR Case (2026)
• Does Unusual Options Flow Mean Insider Trading?
• Gamma Walls Explained

---

Educational content, not investment advice. Options involve risk and are not suitable for all investors. This case description reflects public records; it does not assert conclusions beyond those made by the relevant authorities. Past performance and historical examples do not guarantee future results.